RIOX2 and lung carcinoma: By studying mdig/mina53 expression in lung cancer tissues from 101 patients and correlating the mdig expression with the patient survival time, Komiya et al. [21] reported that mdig/mina53 overexpression is associated with favorable prognosis of the lung cancer patients, esp., for the stage I lung cancer patients.